Background: Little is known about the intention formation process regarding the use of tracheostomy and invasive ventilation (TIV) in amyotrophic lateral sclerosis (ALS) patients in the course of disease progression. Objective: To clarify the intention formation process in the use of TIV in ALS patients for the purpose of providing decision-making support. Methods: We conducted a follow-up study of 14 patients using semi-structured interviews, participant observation, and medical records review. Results: The patients' various intentions regarding the use of TIV were formed as their symptoms progressed (e.g., declining motor, swallowing, and respiratory functions). Other factors influencing their decision were their considerations, such as their ability to communicate after receiving TIV treatment, the degree of support they would receive from professionals after TIV treatment, palliative care for physical distress, value of life after TIV treatment, and to what degree they would be a burden on their families. Conclusion: Patients' intentions regarding the use of TIV were diverse and changeable. The decision of whether or not to use TIV was made out of conviction as well as considering individual experiences of symptom progression and quality of life after TIV use.
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease for which there is currently no cure. Patients with ALS die due to respiratory failure, usually 2 -5 years after onset because of irreversible progression of symptoms such as muscle weakness [1] . Noninvasive ventilation (NIV) and tracheostomy and invasive ventilation (TIV) are used to treat respiratory disorders and can improve survival time [2] [3] [4] . The use of NIV or TIV has been reported to improve the prognosis of ALS patients [5] [6] .
The TIV utilization rate in ALS patients is around 0.5% -30% worldwide [7] , and many patients, including Japanese, do not undergo TIV at present [7] . Factors affecting the varying rates of TIV use in patients with ALS are due in part to differences in health insurance systems [8] , religious views, and cultures [8] . Patients also have concerns about the burden of care on families [9] , symptom progression [9] [10] , and the impossibility of withdrawal after mechanical ventilator use [11] , which affect their assessment of TIV use.
Decision-making is a process in which one selects, from the available options, a solution to a problem [12] . ALS patients need to consider the options and eventually make a decision about TIV use. There has been a tendency to emphasize on only the final decision, i.e., accept or decline, in these patients [8] [9] [13] [14] [15] [16] . On the other hand, it has been shown that their decision could change over time [15] [16] . The thought process behind the decision about TIV that takes place over the course of disease progression, and when the decision is formed and changed, however, is unknown. Furthermore, factors that influence intention formation also are unknown. This knowledge is important for the health care professional who provide care and treat ALS patients who consider TIV use.
The aim of this research was to clarify how ALS patients form and change their intention about TIV use, and what factors influence their intentions.
Methods

Design
We conducted a follow-up study from February 2016 to January 2017 in patients with ALS. We used case study research design [17] , i.e., gathering and examining information from multifaceted viewpoints and integrating it into a theoretical framework, to conduct a survey. We also conducted based on the qualitative approach and made use of semi-structured interviews, participant observation, and a medical records review. The survey was conducted at two institutions: University Hospital A in Tokyo, Japan, which mainly aims to diagnose and treat ALS patients in inpatient and outpatient settings, and Outpatient Clinic B in Chiba,
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Japan, which specializes in neurology and internal medicine and provides visiting care support to ALS patients.
Participants
We used purposive sampling [18] to recruit patients of varying levels of functioning, based on the ALS Functional Rating Scale-Revised (ALSFRS-R) [19] [20], which measures decline in physical functioning specific to ALS. The highest possible score is 48 points, as higher would indicate independence in activities of daily living.
Criteria for inclusion in the research were as follows: 1) adult patients 2) diagnosed with definite ALS or probable ALS according to the revised El Escorial criteria [21] , 3) the patients who are not using TIV, and 4) having no significant cognitive dysfunction or mental disorders. We recruited patients who were hospitalized or who visited the outpatient clinic according to inclusion criteria. Participants who decided to introduce TIV within the research period were withdrawn from the research.
Data Collection
Interviews
We used semi-structured interviews [18] to outline the themes of experiences from the diagnosis of ALS to the present and the concerns about TIV use. Interviews were conducted each time the participants were hospitalized or visited one of the institutions during the research period. The corresponding author (WS) asked participants open-ended questions. Example questions were as follows:
"What has happened since you were diagnosed with ALS?"; "What did you think about TIV use when diagnosed with ALS?"; "Have your thoughts about TIV use changed?"; "What do you think about changing your thoughts?" These questions were used as a guide for the first interview, which was developed by the corresponding author. New questions were added to the interview guide according to the data analysis, which was ongoing at that time. The face-to-face interviews lasted 30 to 60 minutes in a private room in each institution and were digitally recorded and transcribed verbatim. In cases in which participants had dysarthria, written communication or communication boards were used.
Medical Records
The following information was collected from medical records: 1) basic personal information (age, family structure), 2) medical history (onset data, diagnosis data, changes in symptoms, course of ALSFRS-R, experiences of and reasons for hospitalization or emergency outpatient consultation, presence of dyspnea, presence of oxygen therapy, presence of NIV, presence of TIV, and performing suction). Information on participants' intentions of TIV use, TIV-related questions, and decisions on TIV use were also collected. To determine results, the information collected from medical records was verified by the physicians or nurses in charge. 
Data Analysis
In order to clarify the intention formation process of TIV use in ALS patients,
we conducted a time-series analysis [22] . The interview data were analyzed in individual and overall analyses. Then the interview data and medical records data were integrated. We followed a series of steps in our analysis. First, in the individual analysis, we focused on any indications of a change in intention regarding the use of TIV and thoughts about TIV, as well as changes in symptoms, from each participant's transcripts and coded them in short sentences. Second, in the overall analysis, codes based on the results of the individual analyses collectively were classified the same way, and then subcategories were created.
An analysis of medical records data was conducted simultaneously with the individual analysis. The medical records data, specifically past records by physicians and nurses, were evaluated in chronological order to determine ALSFRS-R scores and the progression of symptoms, and the descriptive process of TIV use was elucidated by an individual analysis. The subcategories created in the overall analysis were derived from combining the results of the analysis using medical records data and sorting them as common patterns emerged. Categories sharing the same features were combined into an aspect. Then we used the results of the interview and analysis of the medical record to schematize the relationship between aspects and categories.
Rigor
Reliability was evaluated based on the Lincoln and Guba criteria of trustworthiness [23] . During the interviews, we assessed the agreement between the participants' intent and the researchers' interpretation by asking them as much as possible. We also received evaluations of our data collection, data analysis, and results from five experts in the fields of ALS nursing, neurology, and qualitative research. For transferability purposes, we tried to make our descriptions clear so that the reader can judge whether or not the results of this research are transferable to different settings. To establish dependability, we undertook audits from the supervisor and tried to clearly describe the research process. To establish confirmability, we recorded the research in writing to show evidence of what we accomplished in the research.
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Tokyo Medical and Dental University Medical Hospital (approval number M2000-2323). In consideration of the possibility of the progression of dysarthria, we conducted a survey to evaluate physical conditions to be administered by the attending physicians or nurses. All participants were informed that there was no disadvantage of participation/nonparticipation/refusal to participate in this research. This research was conducted with the written consent of the participants.
Results
Participant Characteristics
There were 14 patients (University Hospital A: 10 patients, Outpatient Clinic B:
4 patients) who agreed to participate in the research and were able to start the investigation. No participants were withdrawn, as none underwent TIV during the research period. All participants' background data are shown in Table 1 .
Eleven of the 14 participants (79%) were male and 3 (21%) were female. The median age was 61 years (range: 32 -79 years). At the time of the first interview, the median number of months from the diagnosis of ALS was 11 (range: 3 -178 months). The mean ± SD number of interviews per participant was 3.5 ± 1.2, for a total of 49 interviews. The ALSFRS-R scores at the first interview were as a 
Interview Data
We identified 102 codes, 29 subcategories, and 8 categories. These were integrated into one of two aspects: intentions regarding the use of TIV, and factors affecting intentions regarding the use of TIV. Each of these is described below. "From looking at books and the internet, it is written that muscles will be worse. I have not progressed yet, but I think this situation means progression of ALS. I'm depressed when I think about TIV; I do not want to think about it."
Intentions Regarding the Use of TIV
(ID: 7)
C: I want to use TIV, but I have not decided it.
Two participants (ID: 12, 13) said that they would like to use TIV, but they did not want to commit to TIV use yet in order to not regret their decision. They needed more information about TIV use and consent from family members about TIV use before they finalized their decision.
"When I came to the hospital, I was shocked by the sudden hospitalization and tracheotomy. In the end it will be comfortable; I would like to use TIV. But I was anxious just the same. If possible, I wanted time to think about using TIV." Participants were aware of the progression of their symptoms due to a decrease in motor, swallowing, and respiratory functions and loss of respiratory function.
Declining motor function was evident to the participants when they had difficulty raising their upper and lower limbs, going up and down stairs, and stumbled while walking on flat ground. Declining swallowing function was evident to the participants when they had difficulty swallowing and painful feelings due to aspiration, and felt in danger of choking to death. Declining respiratory function was evident to the participants when they coughed repeatedly or started oxygen therapy or NIV for dyspnea. Finally, participants were told by a physician that their respiratory functioning was limited ( Table 2 ).
The experience of symptom progression had a pattern in which the speed of progression felt fast and one in which it felt slow. The participants who felt that the progression was fast were unable to adapt to the speed of the symptoms' progression, and felt symptom progression to be unstable. The participants who felt that progression was slow were able to understand the progression of symptoms, change the means of transport and the living environment appropriately, and felt that symptom progression was stable.
B: Considerations regarding quality of life after TIV
The intention of TIV use was influenced by the following consideration: "Whether or not there is a guarantee of good living even after TIV." It consisted of five subcategories, and its contents were related to the ability to communicate after TIV, the degree of support offered by professionals after TIV, palliative care for physical distress, the value of life after TIV, and the burden on their family members. There was no regular order of these ideas that participants used to consider the quality of life after TIV. The five subcategories were ideas that were being considered repeatedly and continually (Table 3) .
The result of considerations regarding quality of life after TIV had a pattern, either unconvinced or convinced. Participants showing the unconvinced pattern felt strong anxiety about symptom progression and had uncertain and vague concerns regarding TIV use. Conversely, participants showing the convinced pattern were actively trying to resolve the question of whether or not to use TIV. Their method was to gather information through discussions with family members and professional staff.
Medical Records Data
In the survey of medical records, analysis of commonalities in symptom progression of each participant was carried out. Even though the participants' Palliative care for physical distress After using TIV, the difficulty I had with breathing finally stopped, so I thought it was good that I used TIV. 
Intention Formation and Factors Affecting Intention Formation on TIV Use
The integration of the interview survey and the medical records survey revealed
that a process was formed by the experience of the symptom progression and considerations regarding quality of life after TIV. The relationship between the order of progressing symptoms, changes in intentions regarding the use of TIV, and considerations regarding quality of life after TIV were schematized (Figure 1 ).
At the time of diagnosis, 11 of 14 participants did not know whether or not to use TIV; three participants did not want to use TIV, but they had not decided not to do it. These intentions surrounding TIV use changed as the participants experienced their symptoms progressing: declining motor function, declining swallowing function, declining respiratory function, and the loss of respiratory function. And three participants' decisions about TIV use, both for and against, could be ultimately explained as resulting from experiences of progressing symptoms, and consideration regarding quality of life after TIV. The only time this happened was when they had experiences of losses of respiratory function.
There were no participants who never changed their intention about the use of TIV from the time of diagnosis until the time of their decision.
Discussion
This research showed diverse and shifting attitudes regarding TIV use in ALS patients. Decisions about using/not using TIV were the results of process to convince their own accompanied by experiences of symptom progression and consideration regarding quality of life after TIV. Third, considerations regarding quality of life after TIV indicate the imagining of a future that patients have still not experienced. Specific concerns patients expressed were the ability to communicate after TIV, the degree of support offered by professionals after TIV, the burden on family members, palliative care for physical distress, and the value of life after TIV. From these five items, we ascertained that ALS patient wished to continue to protect their dignity, as well as their own and others' security.
Finally, the decision regarding the use of TIV required a conviction resulting from experiencing symptom progression and considerations regarding quality of life after TIV. Convincing is defined as to bring to belief, consent, or a course of action [27] . The patients who were not convinced had vague ideas regarding the use of TIV, and they were anxious about symptom progression. Meanwhile, the patients who were convinced were trying to answer the question about TIV use by discussing it with family members and professionals. It was necessary for the ALS patients to have discussion with their families and medical staffs [28] , as the method of gathering information, and the importance of these processes, were emphasized to support decision-making accompanied by conviction.
This research can be utilized to support decision-making concerning the use of TIV in ALS patients in the clinic setting as follows. First, through periodic observation from the time of diagnosis, using an item of decline in physical function as an indicator, it is possible to judge the timing of intention formation and the timing of change about TIV use for the patients with ALS. Second, it is possible to refer to the contents of various intentions at the time of declining physical function. Third, it is possible to establish five items regarding quality of life after TIV as a basic item of information provision.
In order to encourage self-decision regarding the use of TIV in ALS patients, 
Limitations and Further Research
This research has some limitations. First, it used a small number of subjects from limited facilities. To generalize this result, increasing the number of subjects, lengthening the investigation period, and expanding the survey facilities would be necessary. Next, there is the possibility that the presence of family members during part of the interviews may have affected the contents of the patients' remarks. However, we tried to collect various data from many interviews on patients in different situations over the course of a 10-month follow-up study. We believe that it is meaningful to elucidate the intention formation process about the use of TIV and related factors in ALS patients. In order to provide more efficient support for decision-making about the use of TIV in patients with ALS, further research that also examines the medical staff and family members involved in the decision-making process is also needed.
Conclusion
Intentions about the use of TIV in ALS patients were diverse and changeable.
The decision of using/not using TIV for patients with ALS was the result of the conviction process accompanied by experiences of symptom progression and consideration regarding quality of life after TIV use. Early patient education is required in ALS patients.
